Spyre Therapeutics Investor Relations Material
Latest events
Status Update
Spyre Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Spyre Therapeutics Inc
Access all reports
Spyre Therapeutics Inc., previously known as Aeglea BioTherapeutics, is a clinical-stage biotechnology company. It specializes in developing therapeutics for inflammatory bowel disease (IBD), which includes conditions like ulcerative colitis and Crohn's disease. The company's focus is on creating novel and proprietary monoclonal antibody product candidates designed to address unmet needs in IBD care. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Spyre Therapeutics Inc
Corporate Presentation
Spyre Therapeutics Inc
Status Update
Spyre Therapeutics Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
SYRE
Country
🇺🇸 United States